As of Aug 03
| -0.35 / -1.61%|
The 3 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 23.00 and a low estimate of 19.00. The median estimate represents a -6.72% decrease from the last price of 21.44.
The current consensus among 3 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.